NOTABLE LABS, LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9601 USD | -2.13% |
|
-1.53% | -49.20% |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 16.89 | 8.703 | - | - |
| Enterprise Value (EV) 1 | 16.89 | 8.703 | 8.703 | 8.703 |
| P/E ratio | -0.55 x | -0.64 x | -0.36 x | - |
| Yield | - | - | - | - |
| Capitalization / Revenue | 54.5 x | - | - | - |
| EV / Revenue | 54.5 x | - | - | - |
| EV / EBITDA | - | - | - | - |
| EV / FCF | - | 0 x | 0 x | 0 x |
| FCF Yield | - | 133,098% | 216,498% | 285,569% |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 8,936 | 9,018 | - | - |
| Reference price 2 | 1.890 | 0.9650 | 0.9650 | 0.9650 |
| Announcement Date | 11/04/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 0.31 | - | - | - |
| EBITDA | - | - | - | - | - |
| EBIT 1 | - | -14.66 | -16.84 | -19 | -30 |
| Operating Margin | - | -4,728.06% | - | - | - |
| Earnings before Tax (EBT) 1 | - | -11.26 | -16.84 | -19 | -29 |
| Net income 1 | -14.41 | -11.26 | -14.45 | -19 | -29 |
| Net margin | - | -3,633.55% | - | - | - |
| EPS 2 | -1.380 | -3.410 | -1.500 | -2.700 | - |
| Free Cash Flow 1 | - | - | 11,583 | 18,841 | 24,852 |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 01/09/23 | 11/04/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.122 | 0.188 | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| EBIT | -1.75 | -4.402 | - | - | - | - | - |
| Operating Margin | -1,434.43% | -2,341.49% | - | - | - | - | - |
| Earnings before Tax (EBT) | 2.893 | -4.45 | - | - | - | - | - |
| Net income | 2.893 | -4.45 | - | - | - | - | - |
| Net margin | 2,371.31% | -2,367.02% | - | - | - | - | - |
| EPS 2 | 0.1900 | -2.970 | -0.3900 | -0.4300 | -0.5200 | -0.5600 | -0.6000 |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 29/11/23 | 11/04/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | - | - | 11,583 | 18,841 | 24,852 |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex 1 | - | - | 171 | 254 | 378 |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 01/09/23 | 11/04/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.965
USD
Average target price
8
USD
Spread / Average Target
+729.02%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -49.20% | 8.7M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- NTBL Stock
- Financials Notable Labs, Ltd.
